ADVFN Logo ADVFN

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for monitor Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.
Nexien BioPharma Inc (PK)

Nexien BioPharma Inc (PK) (NXEN)

0,0109
0,00
(0,00%)
Geschlossen 19 Januar 10:00PM
Fortg. Diagramm

Stärken Sie Ihr Portfolio: Diskussionen in Echtzeit und umsetzbare Handelsideen.

Wichtige Statistiken und Details

Current Price
0,0109
Gebot
0,0056
Fragen
0,0108
Volumen
-
0,00 Tagesbereich 0,00
0,0041 52-Wochen-Bereich 0,0495
Marktkapitalisierung
Handelsende
0,0109
Handelsbeginn
-
Letzte Trade
Letzter Handelszeitpunkt
Finanzvolumen
-
VWAP
-
Durchschnittliches Volumen (3 Mio.)
23.952
Ausgegebene Aktien
67.472.196
Dividendenrendite
-
Kurs-Gewinn-Verhältnis
-2,86
Gewinn pro Aktie (EPS)
-0
Erlöse
-
Nettogewinn
-239k

Über Nexien BioPharma Inc (PK)

Nexien BioPharma Inc. is a US-based pharmaceutical company engaged in the formulation, development and commercialization of cannabinoid-based pharmaceuticals, in accordance with U.S. Food and Drug Administration ('FDA') pre-clinical and clinical pathways, to address a broad range of medical conditio... Nexien BioPharma Inc. is a US-based pharmaceutical company engaged in the formulation, development and commercialization of cannabinoid-based pharmaceuticals, in accordance with U.S. Food and Drug Administration ('FDA') pre-clinical and clinical pathways, to address a broad range of medical conditions and disorders. Nexien BioPharma's drug development strategy consists of: A. The determination of medical conditions and disorders that could potentially benefit from cannabinoid-based formulations; B. Conducting "freedom to operate" investigations on these conditions; C. The preparation of patent applications and the prosecution of such application and/or the licensing of existing patents; D. Identifying the regulatory pathway with the FDA; and E. Proceeding with pre-clinical and clinical development activities in accordance with FDA protocols for submission to obtain approval for the particular product(s). Mehr anzeigen

Sektor
Drugs And Proprietary-whsl
Branche
Drugs And Proprietary-whsl
Hauptsitz
Lewes, Delaware, USA
Gegründet
-
Nexien BioPharma Inc (PK) is listed in the Drugs And Proprietary-whsl sector of the OTCMarkets with ticker NXEN. The last closing price for Nexien BioPharma (PK) was US$0,01. Over the last year, Nexien BioPharma (PK) shares have traded in a share price range of US$ 0,0041 to US$ 0,0495.

Nexien BioPharma (PK) currently has 67.472.196 shares in issue. The market capitalisation of Nexien BioPharma (PK) is US$735.446,94 . Nexien BioPharma (PK) has a price to earnings ratio (PE ratio) of -2.86.

NXEN Neueste Nachrichten

Zeitraum †ÄnderungÄnderung %HandelsbeginnHochNiedrigDurchsch. VolumenVWAP
10000000CS
40.005291.22807017540.00570.0160.0056285110.01003266CS
12-0.036-76.75906183370.04690.04950.0041239520.01610851CS
26-0.006-35.50295857990.01690.04950.0041212530.01953025CS
52-0.0092-45.77114427860.02010.04950.0041170170.02012826CS
156-0.0369-77.19665271970.04780.1950.0041150280.0595732CS
260-0.053-82.94209702660.06390.4450.0041279040.11060854CS

NXEN - Frequently Asked Questions (FAQ)

What is the current Nexien BioPharma (PK) share price?
The current share price of Nexien BioPharma (PK) is US$ 0,0109
How many Nexien BioPharma (PK) shares are in issue?
Nexien BioPharma (PK) has 67.472.196 shares in issue
What is the market cap of Nexien BioPharma (PK)?
The market capitalisation of Nexien BioPharma (PK) is USD 735,45k
What is the 1 year trading range for Nexien BioPharma (PK) share price?
Nexien BioPharma (PK) has traded in the range of US$ 0,0041 to US$ 0,0495 during the past year
What is the PE ratio of Nexien BioPharma (PK)?
The price to earnings ratio of Nexien BioPharma (PK) is -2,86
What is the reporting currency for Nexien BioPharma (PK)?
Nexien BioPharma (PK) reports financial results in USD
What is the latest annual profit for Nexien BioPharma (PK)?
The latest annual profit of Nexien BioPharma (PK) is USD -239k
What is the registered address of Nexien BioPharma (PK)?
The registered address for Nexien BioPharma (PK) is 16192 COASTAL HIGHWAY, LEWES, DELAWARE, 19958
What is the Nexien BioPharma (PK) website address?
The website address for Nexien BioPharma (PK) is nexienbiopharma.com
Which industry sector does Nexien BioPharma (PK) operate in?
Nexien BioPharma (PK) operates in the DRUGS AND PROPRIETARY-WHSL sector
  • Volumen
  • % Tops
  • % Flops
SymbolPreisVol.
TMGIMarquie Group Inc (PK)
US$ 0,0002
(19.900,00%)
4,03M
SEANSAEAN Group Inc (PK)
US$ 1,87
(18.600,00%)
100
ZPASZoompass Holdings Inc (CE)
US$ 0,0001
(9.900,00%)
675
GMPRGourmet Provisions International Corporation (PK)
US$ 0,0001
(9.900,00%)
35,31M
PLPLPlandai Biotechnology Inc (PK)
US$ 0,0001
(9.900,00%)
18,06M
STNXStartronix International Inc (CE)
US$ 0,000001
(-99,99%)
450
AWINAERWINS Technologies Inc (CE)
US$ 0,000001
(-99,97%)
2,03k
ISOLImage Software Inc (CE)
US$ 0,000001
(-99,91%)
59,2k
NBIONascent Biotech Inc (CE)
US$ 0,0002
(-99,55%)
8,7k
FHBCFernhill Beverage Inc (CE)
US$ 0,000001
(-99,24%)
10k
GTCHGBT Technologies Inc (PK)
US$ 0,0001
(0,00%)
349,77M
VTXBVortex Brands Company (PK)
US$ 0,0002
(0,00%)
297,52M
EMEDElectroMedical Technologies Inc (PK)
US$ 0,0002
(0,00%)
233,53M
PHILPHI Group Inc (PK)
US$ 0,0002
(-33,33%)
184,12M
HMBLHUMBL Inc (PK)
US$ 0,0009
(-5,26%)
179,2M

NXEN Finanzen

Finanzen
Keine Diskussionen Gefunden.
Neuen Thread Erstellen

Kürzlich von Ihnen besucht

Delayed Upgrade Clock